The impact of a best practice advisory for shifting to oral medications: A quality improvement project.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 40679306.
- Also identified by DOI 10.1002/jhm.70127 and PMC identifier 12904682.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We developed a Best Practice Advisory (BPA) to encourage switching from intravenous (IV) to oral (PO) formulations of antimicrobials with equal efficacy, to decrease costs and IV usage. We conducted a prospective study analyzing our BPA's effect on prescribing practices of antimicrobials in the inpatient setting of Stanford Hospital in Palo Alto, CA, over a 22-month period. Our BPA achieved a 1526/6585 (23.2%) acceptance rate and led to decreased use of IV antimicrobials, with substantial direct cost savings of at least $66,976. Future efforts will focus on expanding our BPA to non-antimicrobials given ongoing IV fluid shortages.
Medical subject headings
- Quality Improvement
- Practice Patterns, Physicians'
- Practice Guidelines as Topic
- Anti-Infective Agents
- Anti-Bacterial Agents